Home > Healthcare > Pharmaceuticals > Finished Drug Form > Wound Care Market

Wound Care Market Trends

Report ID: GMI7515
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Wound Care Market Trends

The increasing prevalence of acute and chronic wounds is a significant concern in healthcare with its implications on the wound care market. These wounds can result from various causes including accidents, surgeries, chronic health conditions, and lifestyle factors. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are particularly common.

In the U.S., for instance, it is estimated that there are over 6 million chronic wound cases annually. Furthermore, diabetes-related foot ulcers are a prime example of chronic wounds.
Additionally, growing government initiatives towards trauma cases, developing healthcare infrastructure, and patient support programs will spur the adoption of wound care, thus propelling market revenue.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global wound care industry was valued at USD 21.2 billion in 2022 and is estimated to reach USD 37.3 billion by 2032, owing to the increasing incidence of burn injuries, and prevalence of diabetes.

The advanced wound dressing segment of wound care industry garnered USD 6 billion in 2022 and will continue to see demand attributed to its versatility and effectiveness in wound care.

U.S. wound care market accounted for USD 8 billion in 2022 and is predicted to witness substantial growth over 2023-2032, favored by the increasing government initiatives towards diabetes care.

Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp., Medtronic, 3M Company, and Derma Sciences Inc. (Integra LifeSciences) among others.